Research programme: non-nucleoside reverse transcriptase inhibitors - Paradigm/Parker Hughes Institute
Alternative Names: Thiourea NNRTIs - Paradigm/Parker Hughes InstituteLatest Information Update: 24 Sep 2010
Price :
$50 *
At a glance
- Originator Paradigm Pharmaceuticals; Parker Hughes Institute
- Class Organic sulfur compounds
- Mechanism of Action Non-nucleoside reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 28 Aug 2006 Preclinical trials in HIV infections prevention in USA (Vaginal)